The role of IL-6 blockers in myasthenia gravis
The role of IL-6 blockers in myasthenia gravis
About this item
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Besides conventional therapies, the emergence of molecular therapeutics has prompted the development of innovative medications that target key elements of myasthenia gravis pathogenesis. IL-6 has the potential to modulate immunopathogenic mechanisms in myasthenia gravis upstream of autoantibody effector mechanisms, such as by promoting T-cell polar...
Alternative Titles
Full title
The role of IL-6 blockers in myasthenia gravis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3159816142
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3159816142
Other Identifiers
ISSN
1474-4422,1474-4465
E-ISSN
1474-4465
DOI
10.1016/S1474-4422(24)00528-3
